Luca Agnifili

30PUBLICATIONS
46CO-AUTHORS
Computational neuroscience (incl. mathematical neuroscience and theoretical neuroscience)Photography, video and lens-based practicePredictive and prognostic markersNanotoxicology, health and safetyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (30)

|Aug 27, 2026
Pyrroloquinoline Quinone and NAD+ Metabolism in Glaucoma: A Molecular Rationale for Combined Neuroprotection.

|Jan 28, 2026
Clinical Benefits of Aloe vera Gel in 0.3% Hyaluronate Eyedrops in Glaucoma Therapy-Related Ocular Surface Disease.

Luca Agnifili, Davide Celani, Alessandro Sferra

|Nov 18, 2025
Clinical recommendations for early identification of patients with open-angle glaucoma at higher risk of low adherence to topical treatment: An Italian Delphi consensus.

Roberto G Carassa, Giovanni Pomponio, Luca Agnifili

|May 14, 2025
Efficacy and Safety of XEN63 Gel Stent Implant over 6 Months for Treatment of Glaucoma.

Matteo Sacchi, Sara Giammaria, Gloria Roberti

|Mar 13, 2025
Fighting Bleb Fibrosis After Glaucoma Surgery: Updated Focus on Key Players and Novel Targets for Therapy.

Matteo Sacchi, Davide Tomaselli, Maria Ludovica Ruggeri

|Dec 17, 2024
Italian XEN-Glaucoma Treatment Registry (XEN-GTR): Effectiveness and Safety at 36 Months of XEN45 Implant.

Francesco Oddone, Gloria Roberti, Sara Giammaria

Pageof 5

Frequent Collaborators

7 joint publications

Michele Figus

7 joint publications

Matteo Sacchi

4 joint publications

Chiara Posarelli

4 joint publications

Lorenza Brescia